An Open Label Randomized Multicenter Study to Investigate Pharmacokinetics Pharmacodynamics Safe
Research payments
$3,244,792
Through program year 2022, $3,244,792 in research payments was reported against An Open Label Randomized Multicenter Study to Investigate Pharmacokinetics Pharmacodynamics Safe, across 300 payments, paid by Hoffmann-La Roche Limited.
- Paid by
- Hoffmann-La Roche Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $17,020 | 4 |
| 2021 | Research | $1,049,051 | 145 |
| 2020 | Research | $2,178,722 | 151 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mary Chester Wasko Pittsburgh, PA Named on 22 payments
- Deepa Gotur Houston, TX Named on 15 payments
- Grace McComsey Cleveland, OH Named on 15 payments
- Nandita Nadig Chicago, IL Named on 14 payments
- Joseph Rabin Baltimore, MD Named on 14 payments
- Ronda Oram Park Ridge, IL Named on 13 payments
- Norah Terrault Los Angeles, CA Named on 12 payments
- Gerard Criner Philadelphia, PA Named on 12 payments
- Farah Madhani-Lovely Reno, NV Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.